News Detail

This ResMed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Benzinga · 2d ago

Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

BTIG analyst Douglas Harter downgraded Ellington Financial Inc (NYSE:EFC) from Buy to Neutral. Ellington Financial shares closed at $13.67 on Tuesday. See how other analysts view this stock.
B of A Securities analyst Mariana Perez downgraded Leidos Holdings, Inc. (NYSE:LDOS) from Buy to Neutral and cut the price target from $200 to $125. Leidos shares closed at $113.58 on Tuesday. See how other analysts view this stock.
Goldman Sachs analyst Adrien Duverger downgraded Ermenegildo Zegna N.V. (NYSE: ZGN) from Buy to Neutral and raised the price target from $13.3 to $14. Ermenegildo Zegna shares closed at $14.49 on Tuesday. See how other analysts view this stock.
William Blair analyst Max Smock downgraded Simulations Plus, Inc. (NASDAQ:SLP) from Outperform to Market Perform. Simulations Plus shares closed at $18.24 on Tuesday. See how other analysts view this stock.
Morgan Stanley analyst David Bailey downgraded ResMed Inc. (NYSE:RMD) from Overweight to Equal-Weight and lowered the price target from $286 to $230. ResMed shares closed at $193.94 on Tuesday. See how other analysts view this stock.

Considering buying EFC stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.